Viral haemorrhagic fevers caused by Lassa, Ebola and Marburg viruses

Advances in Experimental Medicine and Biology

Volumn 582, Issue , 2006, Pages 35-44

  Curtis, Nigel ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934436636     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-33026-7_4     Document Type: Review

References (28)

1. Advisory Committee on Dangerous Pathogens. (1996). Management and control of viral haemorrhagic fevers. http://www.hpa.org.uk/infections/topics-az/VHF/ ACDP-VHF-guidance.pdf.
2. Baize, S. (2005). A single shot against Ebola and Marburg virus. Nat Med 11:720-1.
3. Baize, S., Marianneau, P., Georges-Courbot, M.C. and Deubel, V. (2001). Recent advances in vaccines against viral haemorrhagic fevers. Curr Opin Infect Dis 14:513-8.
4. Borio, L., Inglesby, T., Peters, C.J., Schmaljohn, A.L., Hughes, J.M., Jahrling, P.B., Ksiazek, T., Johnson, K.M., Meyerhoff, A., O'toole, T., Ascher, M.S., Bartlett, J., Breman, J.G., Eitzen, E.M., Jr., Hamburg, M., Hauer, J., Henderson, D.A., Johnson, R.T., Kwik, G., Layton, M., Lillibridge, S., Nabel, G.J., Osterholm, M.T., Perl, T.M., Russell, P. and Tonat, K. (2002). Hemorrhagic fever viruses as biological weapons: medical and public health management. Jama 287:2391-405.
5. Centers for Disease Control and Prevention (2005a). http://www.bt.cdc. gov/agent/vhf/index.asp.
6. Centers for Disease Control and Prevention (2005b). http://www.cdc.gov/ ncidod/dvrd/spb/mnpages/ dispages/vhf.htm.
7. Centers for Disease Control and Prevention (2005c). http://www.cdc.gov/ ncidod/dvrd/spb/mnpages/ vhfmanual.htm.
8. Eurosurveillance (2002). http://www.eurosurveillance.org/em/v07n03/ v07n03.pdf.
9. Eurosurveillance (2004). http://www.eurosurveillance.org/em/v09n12/0912- 235.pdf.
10. Feldmann, H., Jones, S., Klenk, H.D. and Schnittler, H.J. (2003). Ebola virus: from discovery to vaccine. Nat Rev Immunol 3:677-85.
11. Fisher-Hoch, S.P. and Mccormick, J.B. (2004). Lassa fever vaccine. Expert Rev Vaccines 3:189-97.
12. Geisbert, T.W. and Hensley, L.E. (2004). Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions. Expert Rev Mol Med 6:1-24.
13. Geisbert, T.W. and Jahrling, P.B. (2004). Exotic emerging viral diseases: progress and challenges. Nat Med 10: S110-21.
14. Health Protection Agency (2005a). http://www.hpa.org.uk/infections/ topics-az/deliberate-release/VHF/homepage.asp.
15. Health Protection Agency (2005b). http://www.hpa.org.uk/infections/ topics-az/VHF/menu.htm.
16. Jones, S.M., Feldmann, H., Stroher, U., Geisbert, J.B., Fernando, L., Grolla, A., Klenk, H.D., Sullivan, N.J., Volchkov, V.E., Fritz, E.A., Daddario, K.M., Hensley, L.E., Jahrling, P.B. and Geisbert, T.W. (2005). Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 11:786-90.
17. Klietmann, W.F. and Ruoff, K.L. (2001). Bioterrorism: implications for the clinical microbiologist. Clin Microbiol Rev 14:364-81.
18. Lowenstein, R. (2004). Deadly viral syndrome mimics. Emerg Med Clin North Am 22:1051-65, ix-x.
19. Mahanty, S. and Bray, M. (2004). Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 4:487-98.
20. Mccormick, J.B., King, I.J., Webb, P.A., Johnson, K.M., O'sullivan, R., Smith, E.S., Trippel, S. and Tong, T.C. (1987). A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155:445-55.
21. Mccormick, J.B., King, I.J., Webb, P.A., Scribner, C.L., Craven, R.B., Johnson, K.M., Elliott, L.H. and Belmont-Williams, R. (1986). Lassa fever. Effective therapy with ribavirin. N Engl J Med 314:20-6.
22. Ndayimirije, N. and Kindhauser, M.K. (2005). Marburg hemorrhagic fever in Angola-fighting fear and a lethal pathogen. N Engl J Med 352:2155-7.
23. Peters, C.J. (2005). Marburg and Ebola-arming ourselves against the deadly filoviruses. N Engl J Med 352:2571-3.
24. Richmond, J.K. and Baglole, D.J. (2003). Lassa fever: epidemiology, clinical features, and social consequences. Bmj 327:1271-5.
25. Salvaggio, M.R. and Baddley, J.W. (2004). Other viral bioweapons: Ebola and Marburg hemorrhagic fever. Dermatol Clin 22:291-302, vi.
26. Sullivan, N.J., Sanchez, A., Rollin, P.E., Yang, Z.Y. and Nabel, G.J. (2000). Development of a preventive vaccine for Ebola virus infection in primates. Nature 408:605-9.
27. World Health Organization (2005a). http://www.who.int/csr/disease/en/.
28. World Health Organization (2005b). http://www.who.int/topics/ haemorrhagic-fevers-viral/en/.